Summarv Toxicitv associated with high-dose recombinant interleukin 2 (rIL-2) therapy simulates a sepsis svndrome. but the mechanism remains unclear. We hvpothesised that translocated gut-origin bacteria may be important. Fifty-one male rats A-ere randomised to receive rIL-2 by intraperitoneal injection at doses (IU) of 1IW (n = 15). 104 (n = 8). 1iO (n = 8) 
1IW (n = 15). 104 (n = 8). 1iO (n = 8) or 102 (n = 8) twice daily. or a saline bolus (n = 12). After 5 days. ileal histomorpholog-was assessed and the mesenteric lymph node complex cultured. Results showed that colomisation of mesenteric lymph nodes with Escherichia coli occurred in all rats treated with I0W IU of rIL-2. and in 620o. 37`o and 12o/ of rats treated with decreasing doses of rIL-2. No translocation was observed in control animals. An increase in submucosal lymphatics and occasional mucosal disruption was seen onlv in the group receiving IW; IU. These data show that rIL-2 promotes bacterial translocation and suggests a mecham'sm that may fuel high-dose rIL-2 toxicity in man.
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The gene for human interleukin 2 was cloned in 1983 (Taniguchi et al.. 1983) . enabling production of abundant quantities of recombinant interleukin 2 (rIL-2). With (Siegel and Pun. 1991) . While many groups are evolving to a new era of adoptive immunotherapy using gene-modified tumour or lymphoid cells in combination with rIL-2 (Rosenberg. 1992; Crowley and Seigler. 1993) , it is unfortunate that at the end of its first decade we are not much wiser about the mechanism of rIL-2 toxicity or its potential modulation.
The pathophysiology of rIL-2-miduced toxicity is associated with increased membrane permeability that leads to fluid and protein losses into visceral and soft tissues (Rosenthein et al.. 1986 ). a so-called vascular leak syndrome. Highdose rIL-2 administration is associated with decreased systemic vascular resistance, an increase in cardiac index. neutrophil leucocytosis. raised serum adrenocorticotrophic hormone and elevated serum levels of tumour necrosis factor alpha (TNF-a) interleukin I (IL-1). and gamma-interferon (IFN-y) (Siegel and Puri. 1991 increase in submucosal vessels, most probably lymphatics, was observed in all rats in this group. Four rats in this group had in addition evidence of mucosal disruption with loss of epithelial cells (Figure 1 ).
Discussion
The theory that translocation of bacteria and endotoxin from the gastrointestinal tract may initiate or exacerbate septic states is increasingly accepted (Van Leeuwen et al.. 1994 (Deitch, 1992 
